Skip to content

Public FDA record

Z-1921-2016: Oxoid Nitrocefin (+ Reconstitution Fluid Batch) REF: SR0112C, Oxoid Ltd. For the rapid chromogenic detec

Recall record Z-1921-2016 for Remel Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1921-2016
Company in FDA record
Remel Inc
FDA record creation date
Jun 7, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Individual bottles of product may produce weak beta-lactamase reactions. Use may result in delayed or false negative reporting.

Source facts

Action
Customers were notified by letter beginning on March 24, 2016.
Initiated
2016-03-24
Root cause
Under Investigation by firm
Terminated
2017-02-13
Distribution
US distribution in MO.
Recall number
Z-1921-2016
Recall status
Terminated
CDRH record ID
144671
FDA record created
2016-06-07
Recall event number
73658

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗